{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:56:40Z","timestamp":1793228200223,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070700"],"award-info":[{"award-number":["82070700"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370698"],"award-info":[{"award-number":["82370698"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["IR56DK135540-01"],"award-info":[{"award-number":["IR56DK135540-01"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National institute of diabetes and digestive and kidney diseases","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The aberrant expression of SET8, a histone methyltransferase that mediates H4 lysine 20 mono-methylation (H4K20me1), is implicated in the pathogenesis of various tumors, however, its role in acute kidney injury (AKI) is unknown. Here, we showed that SET8 and H4K20me1 were upregulated in the murine kidney with AKI induced by cisplatin, along with increased renal tubular cell injury and apoptosis and decreased expression of E-cadherin and Phosphatase and Tensin Homolog (PTEN). Suppression of SET8 by UNC0379 improved renal function, attenuated tubule damage, and restored expression of PTEN but not E-cadherin. UNC0379 was also effective in lessening cisplatin-induced DNA damage response (DDR) as indicated by reduced expression of \u03b3-H2AX, p53, p21, and alleviating cisplatin-impaired autophagy as shown by retained expression of Atg5, Beclin-1, and CHMP2A and enhanced levels of LC3-II in the kidney. Consistently, inhibition of SET8 with either UNC0379 or siRNA mitigated apoptosis and DDR and restored autophagy, along with PTEN preservation in cultured renal proximal tubular epithelial cells (TKPTs) exposed to cisplatin. Further studies showed that inhibition of PTEN with Bpv or siRNA potentiated cisplatin-induced apoptosis and DDR, hindered autophagy, and conversely, alleviated by overexpression of PTEN in TKPTs. Finally, blocking PTEN largely abolished the inhibitory effect of UNC0379 on apoptosis. Taken together, these results suggest that SET8 inhibition protects against cisplatin-induced AKI and renal cell apoptosis through a mechanism associated with the preservation of PTEN, which in turn inhibits DDR and restores autophagy.<\/jats:p>","DOI":"10.1038\/s41419-025-07526-y","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T11:39:23Z","timestamp":1744285163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["SET8 inhibition preserves PTEN to attenuate kidney cell apoptosis in cisplatin nephrotoxicity"],"prefix":"10.1038","volume":"16","author":[{"given":"Xu","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Bayliss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting C.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9719-4187","authenticated-orcid":false,"given":"Shougang","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"key":"7526_CR1","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/967826","volume":"2014","author":"A Ozkok","year":"2014","unstructured":"Ozkok A, Edelstein CL. Pathophysiology of cisplatin-induced acute kidney injury. Biomed Res Int. 2014;2014:967826.","journal-title":"Biomed Res Int"},{"key":"7526_CR2","doi-asserted-by":"crossref","unstructured":"Holditch SJ, Brown CN, Lombardi AM, Nguyen KN, Edelstein CL. Recent advances in models, mechanisms, biomarkers, and interventions in cisplatin-induced acute kidney injury. Int J Mol Sci. 2019;20:3011.","DOI":"10.3390\/ijms20123011"},{"key":"7526_CR3","doi-asserted-by":"crossref","first-page":"Itc66","DOI":"10.7326\/AITC201711070","volume":"167","author":"AS Levey","year":"2017","unstructured":"Levey AS, James MT. Acute kidney injury. Ann Intern Med. 2017;167:Itc66\u2013itc80.","journal-title":"Ann Intern Med"},{"key":"7526_CR4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41581-022-00631-7","volume":"19","author":"C Tang","year":"2023","unstructured":"Tang C, Livingston MJ, Safirstein R, Dong Z. Cisplatin nephrotoxicity: new insights and therapeutic implications. Nat Rev Nephrol. 2023;19:53\u201372.","journal-title":"Nat Rev Nephrol"},{"key":"7526_CR5","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1007\/s00204-015-1633-3","volume":"89","author":"S Zhu","year":"2015","unstructured":"Zhu S, Pabla N, Tang C, He L, Dong Z. DNA damage response in cisplatin-induced nephrotoxicity. Arch Toxicol. 2015;89:2197\u2013205.","journal-title":"Arch Toxicol"},{"key":"7526_CR6","volume":"13","author":"C Zhang","year":"2022","unstructured":"Zhang C, Guan Y, Zou J, Yang X, Bayliss G, Zhuang S. Histone methyltransferase MLL1 drives renal tubular cell apoptosis by p53-dependent repression of E-cadherin during cisplatin-induced acute kidney injury. Cell Death Dis. 2022;13:770.","journal-title":"Cell Death Dis"},{"key":"7526_CR7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41581-020-0309-2","volume":"16","author":"C Tang","year":"2020","unstructured":"Tang C, Livingston MJ, Liu Z, Dong Z. Autophagy in kidney homeostasis and disease. Nat Rev Nephrol. 2020;16:489\u2013508.","journal-title":"Nat Rev Nephrol"},{"key":"7526_CR8","doi-asserted-by":"crossref","first-page":"103154","DOI":"10.18632\/oncotarget.20790","volume":"8","author":"J Zhou","year":"2017","unstructured":"Zhou J, Fan Y, Tang S, Wu H, Zhong J, Huang Z, et al. Inhibition of PTEN activity aggravates cisplatin-induced acute kidney injury. Oncotarget. 2017;8:103154\u201366.","journal-title":"Oncotarget"},{"key":"7526_CR9","volume":"406","author":"Y Wang","year":"2021","unstructured":"Wang Y, Wang X, Wang H, Bao J, Jia N, Huang H, et al. PTEN protects kidney against acute kidney injury by alleviating apoptosis and promoting autophagy via regulating HIF1-alpha and mTOR through PI3K\/Akt pathway. Exp Cell Res. 2021;406:112729.","journal-title":"Exp Cell Res"},{"key":"7526_CR10","volume":"12","author":"H Wang","year":"2021","unstructured":"Wang H, Wang Y, Wang X, Huang H, Bao J, Zhong W, et al. PTEN alleviates maladaptive repair of renal tubular epithelial cells by restoring CHMP2A-mediated phagosome closure. Cell Death Dis. 2021;12:1087.","journal-title":"Cell Death Dis"},{"key":"7526_CR11","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1681\/ASN.2014050463","volume":"26","author":"K Bhatt","year":"2015","unstructured":"Bhatt K, Wei Q, Pabla N, Dong G, Mi QS, Liang M, et al. MicroRNA-687 Induced by Hypoxia-Inducible Factor-1 Targets Phosphatase and Tensin Homolog in Renal Ischemia-Reperfusion Injury. J Am Soc Nephrol. 2015;26:1588\u201396.","journal-title":"J Am Soc Nephrol"},{"key":"7526_CR12","doi-asserted-by":"crossref","unstructured":"Gonzalez-Garcia A, Garrido A, Carrera AC. Targeting PTEN regulation by post translational modifications. Cancers. 2022;14:5613.","DOI":"10.3390\/cancers14225613"},{"key":"7526_CR13","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1158\/2159-8290.CD-18-0083","volume":"9","author":"J Zhang","year":"2019","unstructured":"Zhang J, Lee YR, Dang F, Gan W, Menon AV, Katon JM, et al. PTEN methylation by NSD2 controls cellular sensitivity to DNA damage. Cancer Discov. 2019;9:1306\u201323.","journal-title":"Cancer Discov"},{"key":"7526_CR14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4161\/cc.10.1.14363","volume":"10","author":"S Wu","year":"2011","unstructured":"Wu S, Rice JC. A new regulator of the cell cycle: the PR-Set7 histone methyltransferase. Cell Cycle. 2011;10:68\u201372.","journal-title":"Cell Cycle"},{"key":"7526_CR15","doi-asserted-by":"crossref","first-page":"16429","DOI":"10.1074\/jbc.RA119.009006","volume":"294","author":"K Fukuura","year":"2019","unstructured":"Fukuura K, Inoue Y, Miyajima C, Watanabe S, Tokugawa M, Morishita D, et al. The ubiquitin-specific protease USP17 prevents cellular senescence by stabilizing the methyltransferase SET8 and transcriptionally repressing p21. J Biol Chem. 2019;294:16429\u201339.","journal-title":"J Biol Chem"},{"key":"7526_CR16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1101\/gad.177444.111","volume":"26","author":"DB Beck","year":"2012","unstructured":"Beck DB, Oda H, Shen SS, Reinberg D. PR-Set7 and H4K20me1: at the crossroads of genome integrity, cell cycle, chromosome condensation, and transcription. Genes Dev. 2012;26:325\u201337.","journal-title":"Genes Dev"},{"key":"7526_CR17","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S0960-9822(02)00924-7","volume":"12","author":"J Fang","year":"2002","unstructured":"Fang J, Feng Q, Ketel CS, Wang H, Cao R, Xia L, et al. Purification and functional characterization of SET8, a nucleosomal histone H4-lysine 20-specific methyltransferase. Curr Biol. 2002;12:1086\u201399.","journal-title":"Curr Biol"},{"key":"7526_CR18","doi-asserted-by":"crossref","unstructured":"Veo B, Danis E, Pierce A, Sola I, Wang D, Foreman NK, et al. Combined functional genomic and chemical screens identify SETD8 as a therapeutic target in MYC-driven medulloblastoma. JCI Insight. 2019;4:e122933.","DOI":"10.1172\/jci.insight.122933"},{"key":"7526_CR19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ccell.2016.12.002","volume":"31","author":"V Veschi","year":"2017","unstructured":"Veschi V, Liu Z, Voss TC, Ozbun L, Gryder B, Yan C, et al. Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk Neuroblastoma. Cancer Cell. 2017;31:50\u201363.","journal-title":"Cancer Cell"},{"key":"7526_CR20","doi-asserted-by":"crossref","first-page":"6822","DOI":"10.1021\/jm500871s","volume":"57","author":"A Ma","year":"2014","unstructured":"Ma A, Yu W, Li F, Bleich RM, Herold JM, Butler KV, et al. Discovery of a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8. J Med Chem. 2014;57:6822\u201333.","journal-title":"J Med Chem"},{"key":"7526_CR21","volume":"14","author":"L Xu","year":"2022","unstructured":"Xu L, Zhang L, Sun J, Hu X, Kalvakolanu DV, Ren H, et al. Roles for the methyltransferase SETD8 in DNA damage repair. Clin Epigenetics. 2022;14:34.","journal-title":"Clin Epigenetics"},{"key":"7526_CR22","doi-asserted-by":"crossref","first-page":"eabo0322","DOI":"10.1126\/sciadv.abo0322","volume":"8","author":"B Jiang","year":"2022","unstructured":"Jiang B, Wu X, Meng F, Si L, Cao S, Dong Y, et al. Progerin modulates the IGF-1R\/Akt signaling involved in aging. Sci Adv. 2022;8:eabo0322.","journal-title":"Sci Adv"},{"key":"7526_CR23","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41574-021-00551-9","volume":"17","author":"M Kitada","year":"2021","unstructured":"Kitada M, Koya D. Autophagy in metabolic disease and ageing. Nat Rev Endocrinol 2021;17:647\u201361.","journal-title":"Nat Rev Endocrinol"},{"key":"7526_CR24","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1681\/ASN.2007090982","volume":"19","author":"B Zhang","year":"2008","unstructured":"Zhang B, Ramesh G, Uematsu S, Akira S, Reeves WB. TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity. J Am Soc Nephrol. 2008;19:923\u201332.","journal-title":"J Am Soc Nephrol"},{"key":"7526_CR25","doi-asserted-by":"crossref","unstructured":"Kim DU, Kim DG, Choi JW, Shin JY, Kweon B, Zhou Z, et al. Loganin attenuates the severity of acute kidney injury induced by cisplatin through the inhibition of erk activation in mice. Int J Mol Sci. 2021;22:1421.","DOI":"10.3390\/ijms22031421"},{"key":"7526_CR26","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1242\/jcs.01201","volume":"117","author":"Y Murayama","year":"2004","unstructured":"Murayama Y, Miyagawa J, Oritani K, Yoshida H, Yamamoto K, Kishida O, et al. CD9-mediated activation of the p46 Shc isoform leads to apoptosis in cancer cells. J Cell Sci. 2004;117:3379\u201388.","journal-title":"J Cell Sci"},{"key":"7526_CR27","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1083\/jcb.146.2.389","volume":"146","author":"J Gu","year":"1999","unstructured":"Gu J, Tamura M, Pankov R, Danen EH, Takino T, Matsumoto K, et al. Shc and FAK differentially regulate cell motility and directionality modulated by PTEN. J Cell Biol. 1999;146:389\u2013403.","journal-title":"J Cell Biol"},{"key":"7526_CR28","volume":"273","author":"Y Luo","year":"2021","unstructured":"Luo Y, Huang Z, Mou T, Pu J, Li T, Li Z, et al. SET8 mitigates hepatic ischemia\/reperfusion injury in mice by suppressing MARK4\/NLRP3 inflammasome pathway. Life Sci. 2021;273:119286.","journal-title":"Life Sci"},{"key":"7526_CR29","volume":"11","author":"LF Xu","year":"2021","unstructured":"Xu LF, Shi L, Zhang SS, Ding PS, Ma F, Song KD, et al. LukS-PV induces apoptosis via the SET8-H4K20me1-PIK3CB axis in human acute myeloid leukemia cells. Front Oncol. 2021;11:718791.","journal-title":"Front Oncol"},{"key":"7526_CR30","volume":"2023","author":"X Li","year":"2023","unstructured":"Li X, Qian Y, Shen W, Zhang S, Han H, Zhang Y, et al. Mechanism of SET8 activates the Nrf2-KEAP1-ARE signaling pathway to promote the recovery of motor function after spinal cord injury. Mediators Inflamm. 2023;2023:4420592.","journal-title":"Mediators Inflamm"},{"key":"7526_CR31","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/mc.21903","volume":"52","author":"A Mukherjee","year":"2013","unstructured":"Mukherjee A, Karmakar P. Attenuation of PTEN perturbs genomic stability via activation of Akt and down-regulation of Rad51 in human embryonic kidney cells. Mol Carcinog. 2013;52:611\u20138.","journal-title":"Mol Carcinog"},{"key":"7526_CR32","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/s12276-020-00509-3","volume":"52","author":"X Shen","year":"2020","unstructured":"Shen X, Chen X, Wang J, Liu J, Wang Z, Hua Q, et al. SET8 suppression mediates high glucose-induced vascular endothelial inflammation via the upregulation of PTEN. Exp Mol Med. 2020;52:1715\u201329.","journal-title":"Exp Mol Med"},{"key":"7526_CR33","first-page":"9053","volume":"47","author":"H Zhang","year":"2019","unstructured":"Zhang H, Gao Q, Tan S, You J, Lyu C, Zhang Y, et al. SET8 prevents excessive DNA methylation by methylation-mediated degradation of UHRF1 and DNMT1. Nucleic Acids Res. 2019;47:9053\u201368.","journal-title":"Nucleic Acids Res"},{"key":"7526_CR34","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrm3330","volume":"13","author":"MS Song","year":"2012","unstructured":"Song MS, Salmena L, Pandolfi PP. The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol. 2012;13:283\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7526_CR35","volume":"327","author":"H Wu","year":"2023","unstructured":"Wu H, Shi X, Zang Y, Zhao X, Liu X, Wang W, et al. 7-hydroxycoumarin-\u03b2-D-glucuronide protects against cisplatin-induced acute kidney injury via inhibiting p38 MAPK-mediated apoptosis in mice. Life Sci. 2023;327:121864.","journal-title":"Life Sci"},{"key":"7526_CR36","volume":"10","author":"Z Wang","year":"2020","unstructured":"Wang Z, Sun W, Sun X, Wang Y, Zhou M. Kaempferol ameliorates Cisplatin induced nephrotoxicity by modulating oxidative stress, inflammation and apoptosis via ERK and NF-\u03baB pathways. AMB Express. 2020;10:58.","journal-title":"AMB Express"},{"key":"7526_CR37","volume":"11","author":"H Wang","year":"2020","unstructured":"Wang H, Xia W, Long G, Pei Z, Li Y, Wu M, et al. Isoquercitrin ameliorates cisplatin-induced nephrotoxicity via the inhibition of apoptosis, inflammation, and oxidative stress. Front Pharmacol. 2020;11:599416.","journal-title":"Front Pharmacol"},{"key":"7526_CR38","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-018-1471-1","volume":"16","author":"IW Achkar","year":"2018","unstructured":"Achkar IW, Abdulrahman N, Al-Sulaiti H, Joseph JM, Uddin S, Mraiche F. Cisplatin based therapy: the role of the mitogen activated protein kinase signaling pathway. J Transl Med. 2018;16:96.","journal-title":"J Transl Med"},{"key":"7526_CR39","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115484","volume":"418","author":"X Wang","year":"2021","unstructured":"Wang X, Gong Q, Song C, Fang J, Yang Y, Liang X, et al. Berberine-photodynamic therapy sensitizes melanoma cells to cisplatin-induced apoptosis through ROS-mediated P38 MAPK pathways. Toxicology Appl Pharmacol. 2021;418:115484.","journal-title":"Toxicology Appl Pharmacol"},{"key":"7526_CR40","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41392-020-0196-9","volume":"5","author":"L Chen","year":"2020","unstructured":"Chen L, Liu S, Tao Y. Regulating tumor suppressor genes: post-translational modifications. Signal Transduct Target Ther. 2020;5:90.","journal-title":"Signal Transduct Target Ther"},{"key":"7526_CR41","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3109\/10799893.2012.695798","volume":"32","author":"MA Chetram","year":"2012","unstructured":"Chetram MA, Hinton CV. PTEN regulation of ERK1\/2 signaling in cancer. J Recept Signal Transduct Res. 2012;32:190\u20135.","journal-title":"J Recept Signal Transduct Res"},{"key":"7526_CR42","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.canlet.2010.05.007","volume":"297","author":"JS Clark","year":"2010","unstructured":"Clark JS, Faisal A, Baliga R, Nagamine Y, Arany I. Cisplatin induces apoptosis through the ERK-p66shc pathway in renal proximal tubule cells. Cancer Lett. 2010;297:165\u201370.","journal-title":"Cancer Lett"},{"key":"7526_CR43","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1172\/JCI111524","volume":"74","author":"MS Paller","year":"1984","unstructured":"Paller MS, Hoidal JR, Ferris TF. Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Investig. 1984;74:1156\u201364.","journal-title":"J Clin Investig"},{"key":"7526_CR44","first-page":"e22712","volume":"37","author":"J Zou","year":"2023","unstructured":"Zou J, Yu C, Zhang C, Guan Y, Zhang Y, Tolbert E, et al. Inhibition of MLL1-menin interaction attenuates renal fibrosis in obstructive nephropathy. FASEB J. 2023;37:e22712.","journal-title":"FASEB J"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07526-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07526-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07526-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T12:53:50Z","timestamp":1744289630000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07526-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7526"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07526-y","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,31]]},"assertion":[{"value":"19 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experimental protocols were performed according to the National Institutes of Health Guidelines on the Care and Use of Laboratory Animals and were approved by the Lifespan Animal Welfare Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"226"}}